title: Glycemia Lowering and Risk for Heart Failure: Recent Evidence from Studies of Dipeptidyl Peptidase Inhibition.
authors.affiliation: From the Division of Cardiovascular Medicine, University of Maryland, Baltimore.
authors.forename: Jixin
authors.initials: J
authors.lastname: Zhong
authors.affiliation: From the Division of Cardiovascular Medicine, University of Maryland, Baltimore.
authors.forename: Aditya
authors.initials: A
authors.lastname: Goud
authors.affiliation: From the Division of Cardiovascular Medicine, University of Maryland, Baltimore. srajagopalan@medicine.umaryland.edu.
authors.forename: Sanjay
authors.initials: S
authors.lastname: Rajagopalan
mesh_terms: D000818:Animals; D015415:Biomarkers / Q000097:blood; D001786:Blood Glucose / Q000187:drug effects* / Q000378:metabolism; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D018819:Dipeptidyl Peptidase 4 / Q000378:metabolism*; D054873:Dipeptidyl-Peptidase IV Inhibitors / Q000627:therapeutic use*; D006333:Heart Failure / Q000175:diagnosis / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D018570:Risk Assessment; D012307:Risk Factors; D016896:Treatment Outcome
chemical_list: D015415:Biomarkers; D001786:Blood Glucose; D054873:Dipeptidyl-Peptidase IV Inhibitors; C042807:DPP4 protein, human; D018819:Dipeptidyl Peptidase 4
keywords: diabetes mellitus; glucagon-like peptide 1; heart failure; human DPP4 protein